# Vitalant – FDA Inspection, Jun 11, 2024

Source: https://www.keypedia.com/records/fda_inspections/vitalant/592d46db-6b72-42ed-a2d2-f5ed063d1a37
Source feed: FDA_Inspections

> FDA inspection 1241811 of Vitalant, June 11, 2024. Classification: No Action Indicated (NAI). 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1241811
- Company Name: Vitalant
- Inspection Date: 2024-06-11
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1089686 - 2019-03-29
- FDA Inspection 988683 - 2016-08-31
- FDA Inspection 854838 - 2013-11-01
- FDA Inspection 795164 - 2012-08-13
- FDA Inspection 600001 - 2009-07-24

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/shelley-h-beausoleil/1212116b-e24d-4bbc-a27a-5c16334d573e)

Company: https://www.keypedia.com/companies/vitalant/3f7c3533-9a3c-43cc-b283-fbbeb668a2a8

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d